XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock, Non-Exchangeable
Common Stock, Exchangeable
Total PENN Stockholders’ Equity
Total PENN Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Common Stock
Common Stock, Non-Exchangeable
Common Stock
Common Stock, Exchangeable
Treasury Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjustment
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021             775                      
Beginning balance (in shares) at Dec. 31, 2021                 169,561,883 653,059                
Beginning balance at Dec. 31, 2021 $ 4,097.1 $ (69.3)     $ 4,097.8 $ (69.3) $ 25.8   $ 1.7 $ 0.0 $ (28.4) $ 4,239.6 $ (88.2) $ (86.5) $ 18.9 $ (54.4)   $ (0.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Share-based compensation arrangements (in shares)                 188,273                  
Share-based compensation arrangements $ 17.0       17.0             17.0            
Share repurchases (in shares) (3,802,408)               (3,802,408)                  
Share repurchases $ (175.1)       (175.1)           (175.1)              
Preferred stock conversions (Note 13) (in shares)             (194)   194,200                  
Preferred stock conversions (Note 13) 0.0       0.0   $ (6.4)         6.4            
Exchangeable share conversions (Note 13) (in shares)               (19,870) 19,870                  
Currency translation adjustment 35.8       35.8                     35.8    
Net income (loss) 51.6       51.7                 51.7       (0.1)
Other (4.4)       (4.4)             (4.4)            
Ending balance (in shares) at Mar. 31, 2022             581                      
Ending balance (in shares) at Mar. 31, 2022                 166,161,818 633,189                
Ending balance at Mar. 31, 2022 $ 3,952.7       3,953.5   $ 19.4   $ 1.7 $ 0.0 (203.5) 4,170.4   (15.9)   (18.6)   (0.8)
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                                  
Beginning balance (in shares) at Dec. 31, 2021             775                      
Beginning balance (in shares) at Dec. 31, 2021                 169,561,883 653,059                
Beginning balance at Dec. 31, 2021 $ 4,097.1 (69.3)     4,097.8 (69.3) $ 25.8   $ 1.7 $ 0.0 (28.4) 4,239.6 $ (88.2) (86.5) $ 18.9 (54.4)   (0.7)
Ending balance (in shares) at Dec. 31, 2022             581                      
Ending balance (in shares) at Dec. 31, 2022     152,903,708 620,019         152,903,708 620,019                
Ending balance at Dec. 31, 2022 3,596.6 $ 8.2     3,597.7 $ 8.2 $ 19.4   $ 1.7 $ 0.0 (629.5) 4,220.2   154.5   (168.6) $ 8.2 (1.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Share-based compensation arrangements (in shares)                 148,439                  
Share-based compensation arrangements 16.5       16.5             16.5            
Share issuance in connection with acquisitions (in shares)                 2,442,809                  
Share issuance in connection with acquisitions $ 80.8       80.8           80.8            
Share repurchases (in shares) (1,646,963)               (1,646,963)                  
Share repurchases $ (50.0)       (50.0)           (50.0)              
Preferred stock conversions (Note 13) (in shares)             227   226,800                  
Preferred stock conversions (Note 13) 0.0       0.0   $ (7.6)         7.6            
Exchangeable share issuance (Note 13) (in shares)                   2,854                
Exchangeable share conversions (Note 13) (in shares)                 62,115 (62,115)                
Currency translation adjustment 8.2                                  
Net income (loss) 514.4       514.5                 514.5       (0.1)
Other 8.6       8.6     $ 0.1       8.5            
Ending balance (in shares) at Mar. 31, 2023             354                      
Ending balance (in shares) at Mar. 31, 2023     154,136,908 560,758         154,136,908 560,758                
Ending balance at Mar. 31, 2023 $ 4,175.1       $ 4,176.3   $ 11.8   $ 1.8 $ 0.0 $ (679.5) $ 4,333.6   $ 669.0   $ (160.4)   $ (1.2)